To highlight the importance of lifesaving cancer research, National Cancer Research Month, led by the American Association for Cancer Research (AACR), is recognized during May. Rutgers Cancer Institute of New Jersey prevails, as the state’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, together with RWJBarnabas Health, to address the cancer research demands of one of the most diverse and densely populated states in the nation. From genetic implications to exploring the impact of self-cannibalization of cancer cells, experts at Rutgers Cancer Institute are always working to translate cancer discoveries into today’s treatments. Learn more about Research at Rutgers Cancer Institute.
Research Highlights and News
Extensive Research Underway to Address Cancer Disparities
The topic of cancer disparities and equity, which aims to understand why some groups of people may be more or less likely to develop cancer, experience cancer-related health problems, or have less frequent use of screening tests than other groups of people, is one of many research areas being explored and critical to progress against the disease. Rutgers Cancer Institute of New Jersey has curated a selection of ongoing research focusing on cancer disparities.
Exploring Sun Protection Behaviors Among U.S. Hispanic Outdoor Workers
In a recent study, researchers at Rutgers Cancer Institute examined both sunburns and sun protection behaviors among male Hispanic outdoor day laborers in the Northeast U.S. Carolyn J. Heckman, PhD, co-leader of the Cancer Prevention and Control Program at Rutgers Cancer Institute and an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, is corresponding author and shares more on the work which was published in the February 2022 online edition of the International Journal of Environmental Research and Public Health (DOI: 10.3390/ijerph19052524).
$3.5 Million NIH Grant to Rutgers Cancer Institute of New Jersey will Support a new ‘Lens’ in Lung Cancer Screening
With the aid of a $3.5 million National Institutes of Health grant (R01HL158850), investigators from Rutgers Cancer Institute of New Jersey – the state’s only National Cancer Institute-designated Comprehensive Cancer Center – along with Holden Cancer Center at the University of Iowa, and the University of Texas MD Anderson Cancer Center, are collaborating on a project to address lung cancer screening disparities among individuals with a history of heavy smoking.
$3M Grant Supports Expansion of Digital Intervention for Skin Self Examination among Skin Cancer Survivors
With the aid of a $3 million National Cancer Institute grant (R01CA2645-01), Rutgers Cancer Institute of New Jersey researchers aim to enhance the effectiveness of a digital intervention that supports skin self-examination for survivors of melanoma, the deadliest form of skin cancer.
$3.5 Million NIH Grant will Help Harness Worldwide Big Data to Enhance Decision Support in Hodgkin Lymphoma
With the aid of a recently awarded $3.5 million, five-year National Cancer Institute grant (R01CA262265), Rutgers Cancer Institute, New Jersey’s only NCI-designated Comprehensive Cancer Center, and Tufts Medical Center in Boston are collaborating on groundbreaking work that is unifying global multi-source big data in order to enhance clinical decision support for improved acute and long-term outcomes for Hodgkin lymphoma patients around the world.